Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abortion, spontaneous
advances in neurology
adverse drug reaction
alemtuzumab
anaphylaxis
anesthesia, epidural
anesthesia, spinal
arrhythmia, cardiac
atorvastatin
autoimmune disease
axonal degeneration
azathioprine
B cell lymphocytes
Barkhof MR criteria for MS
BENEFIT study
bladder dysfunction
blood brain barrier
bradycardia
bradykinesia
brain atrophy
brain volume
breast feeding
carcinoma
carcinoma of breast
central nervous system, infection of
children
chills
compliance
complications
conduction block
controversies in neurology
cop 1
cost effectiveness
cotton-wool spots
cyclophosphamide
cyclosporine
cytokines
daclizumab
depression
disability rating scale, neurological
disability, neurological
efficacy
electrocardiogram, abnormal
emotional lability
encephalitis, viral
EVIDENCE trial
evidence-based research
facial weakness
fatigue
fetus
fever
fingolimod
flu-like illness
fundus, abnormality of
gadolinium
gammaglobulin therapy, intravenous
genetic neurologic disorders
headache
hepatic failure
hepatitis
herpes simplex encephalitis
herpes simplex virus
herpes virus
herpes virus infection
herpes zoster
herpes zoster, disseminated
HLA
human herpesvirus 6
hydrocephalus, exvacuo
iatrogenic neurologic disorders
ibuprofen
idiopathic thrombocytopenic purpura
immunomodulation
immunosuppression
immunosuppressive agents
immunotherapy
infection
interferon
interferon alpha
interferon antibodies
interferon beta 1-a
interferon beta 1-b
interferon gamma
interleukin 6
intrauterine
JC virus
leukopenia
liver disease
liver function enzymes
low birth weight
lymphopenia
menses
menses, irregular
methotrexate
monoclonal antibodies
mortality
MRI
MRI, abnormal
MRI, black holes on
MRI, contrast enhanced
MRI, demyelinating disease
MRI, hypointense signal foci on
MRI, lesion burden
MRI, serial
MRI, volumetry
multiple sclerosis
multiple sclerosis, children
multiple sclerosis, chronic progressive
multiple sclerosis, clinical patterns
multiple sclerosis, conversion to clinically definite
multiple sclerosis, cost of
multiple sclerosis, diagnosis of
multiple sclerosis, diagnostic criteria
multiple sclerosis, disability status scale
multiple sclerosis, early onset
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, prognosis
multiple sclerosis, relapsing
multiple sclerosis, secondary progressive
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
multiple sclerosis, worsening
muscle pain
natalizumab
neuropathology
neuropathy
neuropathy, medication induced
neutralizing antibodies
neutralizing antibodies, cross-reactive
neutropenia
nonsteroidal anti-inflammatory drug
ocrelizumab
opportunistic infection
optic neuritis
optic neuritis, treatment of
oxybutynin
pancreatitis
patient information and support
pentoxifylline
plasmapheresis
polymerase chain reaction
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
progressive multifocal leucoencephalopathy
quality of life
research
retinopathy
review article
risk-benefit assessment
rituximab
safety
serum alanine aminotransferase
serum glutamic oxaloacetic transaminase
skin, lesions in neurologic disorders
spasticity
statin therapy
steroid
steroid therapy, CNS treatment and complications with
T cell lymphocytes
thrombocytopenia
treatment of neurologic disorder
tumor necrosis factor
tumor necrosis factor inhibitor
urinary tract infection
ventricular enlargement
viral infection
viral infection, CNS
viral infection, reactivation
weakness
white matter disease
Showing articles 350 to 400 of 1445 << Previous Next >>

Fulminant Encephalopathy With Basal Ganglia Hyperintensities in HIV-Infected Drug Users
Neurol 76:787-794, Newsome,S.D.,et al, 2011

Longitudinal Assessment of A-beta and Cognition in Aging and Alzheimer Disease
Ann Neurol 69:181-192, Villemagne,V.L.,et al, 2011

Phase III Dose-Comparison Study of Glatiramer Acetate for Multiple Sclerosis
Ann Neurol 69:75-82, Comi,G.,et al, 2011

Differential Diagnosis of Bilateral Abnormalities of the Basal Ganglia and Thalamus
RadioGraphics 31:5-30, Hegde,A.N.,et al, 2011

Increasing Incidence of Ischemic Stroke in Patients With HIV Infection
Neurol 76:444-450, Ovbiagele,B. &Nath,A., 2011

Hydrocephalus in Patients with Neurofibromatosis Type 1: MR Imaging Findings and the Outcome of Endoscopic Third Ventriculostomy
AJNR 32:643-46, Dincer, A.,et al, 2011

Transition to Adult Care for Children with Chronic Neurological Disorders
Ann Neurol 69:437-444, Camfiled, P. & Camfield, C., 2011

Cerebral microhemorrhage and brain B-amyloid in aging and Alzheimer disease
Neurol 77:48-54, Yates, P.A.,et al, 2011

Cerebral Amyloid Angiopathy Related Inflammation: Three Case Reports and a Review
JNNP 82:20-26, Chung,K.K.,et al, 2011

Toxoplasmic Encephalitis IRIS in HIV-Infected Patients
JNNP 82:691-693, Martin-Blondel, G.,et al, 2011

HIV Disease in the Caribbean
Top Antivir Med 19:e1-e5, Pape, J.W.,et al, 2011

Utility of Molecular and Serodiagnostic Tools in Cerebral Toxoplasmosis With and Without Tuberculous Meningitis in AIDS Patients
Ann Indian Acad Neurol 13:263-274, Adurthi, S.,et al, 2010

Cerebral Toxoplasmosis in Acquired Immunodeficiency Syndrome (AIDS) Patients also Provides Unifying Pathophysiologic Hypotheses for Holmes Tremor
BMC Neurol 10:37, Lekoubou, A.,et al, 2010

Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010

Clinicopath Conf, Inflamatory Cerebral Amyloid Angiopathy,
NEJM 363:373-381, Case 22-2010, 2010

Serial MRI and CSF Biomarkers in Normal Aging, MCI, and AD
Neurol 75:143-151, Vemuri,P., et al, 2010

JC Virus Infection of the Brain
AJNR 31:1564-1576, Bag,A.K.,et al, 2010

Coccidioidal Meningitis: Clinical Presentation and Management in the Fluconazole Era
Medicine 89:251-284, Mathisen,G.,et al, 2010

Alzheimers Disease
NEJM 362:329-344, Querfurth,H.W. &LaFerla,F.M., 2010

C-PIB Binding is Increased in Patients with Cerebral Amyloid Angiopathy-related Hemorrhage
Neurol 74:487-493, Ly,J.V.,et al, 2010

Glucose Transporter-1 Deficiency Syndrome: The Expanding Clinical and Genetic Spectrum of a Treatable Disorder
Brain 133:655-670, Leen,W.G., et al, 2010

Is the Diagnosis at Hand?
The Lancet 375:1134, Holmes,M.V., et al, 2010

Absence Epilepsies With Widely Variable Onset are a Key Feature of Familial GLUT1 Deficiency
Neurol 75:432-440, Mullen,S.A., et al, 2010

The erythrocyte sedimentation rate in HIV: a neglected parameter?
AIDS 24:2773-2775, Lowe, D., 2010

Imaging Manifestations of Progressive Multifocal Leukoencephalopathy
Clinical Radiol 65:431-439, Shah,R.,et al, 2010

The stages and natural history of HIV infection
Up to date: Sept, Bartlett, J.G.,et al, 2010

Multiple Ring-Enhancing Lesions of the Brain
J Postgrad Med 56:307-316, Garg, R.K. & Sinha, M.K., 2010

AIDS - Related Lymphomas: Primary CNS Lymphoma
UpToDate, April, Doweiko, J.P., 2010

Chronic Inflammatory Demyelinating Polyneuropathy: Etiology, Clinical Features, and Diagnosis
UpToDate, Sept, Lewis, R., 2010

AIDS-Related Lymphomas: Epidemiology, Risk Factors, and Pathobiology
UpToDate, Sept, Kaplan, L.D.,et al, 2010

Eccentric Target Sign in Cerebral Toxoplasmosis - Neuropathological Correlate to the Imaging Feature
J Magn Reson Imaging 31:1469-1472, Kumar, G.S.,et al, 2010

Plasmablastic Lymphoma: CNS Involvement, Coexistence of Other Malignancies, Possible Viral Etiology, and Dismal Outcome
Ann Hematol 88:351-358, Ustun, C.,et al, 2009

Frequent Hemorrhagic Lesions in Cerebral Toxoplasmosis in AIDS Patients
J Neuroimaging 19:169-173, Bhagavati, S. & Choe, J., 2009

Small Fiber Neuropathy: A Burning Problem
Cleve Clin J Med 76:297-305, Tavee, J. & Zhou, L., 2009

The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009

Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009

Clinical and Mutational Spectrum of Neurofibromatosis Type 1-Like Syndrome
JAMA 302:2111-2118, 2150, 2170, Messian,L.,et al, 2009

Aicardi-Gouti�res Syndrome: Neuroradiologic Findings and Follow-up
AJNR 30:1971-1976, Uggetti,C.,et al, 2009

Effect of Glatiramer Acetate on Conversion to Clinically Definite Multiple Sclerosis in Patients with Clinically Isolated Syndrome (PreCISe study): A Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 374:1503-1511, 1475, Martinelli,G.,et al, 2009

Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009

Neurologic Immune Reconstitution Inflammatory Syndrome in HIV/AIDS: Outcome and Epidemiology
Neurol 72:835-841, McCombe,J.A.,et al, 2009

Genetic Aspects of Alzheimer Disease
The Neurologist 15:80-86, Williamson,J.,et al, 2009

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

PML-IRIS in Patients with HIV Infection: Clinical Manifestations and Treatment with Steroids
Neurol 72:1458-1464,1454, Tan,K.,et al, 2009

Clinicopath Conf, Acute HIV-1 Infection
NEJM 360:1540-1548, Case 11-2009, 2009

Parkinsonism in HIV-Infected Patients on Highly Active Antiretroviral Therapy
Neurol 73:401-403, Tisch,S. &Brew,B., 2009

CSF Biomarkers and Incipient Alzheimer Disease in Patients with Mild Cognitive Impairment
JAMA 302:385-393,436,452, Mattsson,N.,et al, 2009

Aicardi-Gouti�res Syndrome
Br Med Bull 89:183-201, Orcesi, S.,et al, 2009



Showing articles 350 to 400 of 1445 << Previous Next >>